Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $74,721 - $107,274
-1,199 Reduced 31.74%
2,578 $221,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $137,120 - $156,627
-2,303 Reduced 37.88%
3,777 $233,000
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $133,679 - $150,563
-2,316 Reduced 27.58%
6,080 $376,000
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $280,680 - $351,722
-4,846 Reduced 36.6%
8,396 $499,000
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $137,275 - $148,104
-2,028 Reduced 13.28%
13,242 $925,000
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $409,508 - $447,446
-6,452 Reduced 29.7%
15,270 $1.05 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $193,560 - $220,851
-3,226 Reduced 12.93%
21,722 $1.4 Million
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $4,078 - $4,647
-72 Reduced 0.29%
24,948 $1.45 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $6,458 - $8,120
104 Added 0.42%
25,020 $1.58 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $87,676 - $101,808
1,212 Added 5.11%
24,916 $1.92 Million
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $11,022 - $14,118
176 Added 0.75%
23,704 $1.77 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $177,958 - $195,748
-2,888 Reduced 10.93%
23,528 $1.53 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $25,129 - $27,738
-402 Reduced 1.5%
26,416 $1.67 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $45,165 - $50,647
730 Added 2.8%
26,818 $1.81 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $119,870 - $134,285
1,917 Added 7.93%
26,088 $1.7 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $95,168 - $124,188
1,572 Added 6.96%
24,171 $1.51 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $24,948 - $27,622
350 Added 1.57%
22,599 $1.75 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $131,122 - $152,949
2,021 Added 9.99%
22,249 $1.58 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $19,375 - $23,620
-266 Reduced 1.3%
20,228 $1.53 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $103,096 - $121,020
-1,449 Reduced 6.6%
20,494 $1.47 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $1.58 Million - $1.88 Million
21,943
21,943 $1.78 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bragg Financial Advisors, Inc Portfolio

Follow Bragg Financial Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bragg Financial Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bragg Financial Advisors, Inc with notifications on news.